Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by
significant morbidity and mortality, poor functional capacity and quality of life, and high costs …

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64
million people globally. Although the incidence of HF has stabilised worldwide and seems to …

After the publication of the revised edition, therapeutic drugs described in “Future Treatment”
were approved and important evidence for pharmacologic therapy and nonpharmacologic …

Heart Failure Society (JHFS). The working committee for this project includes members and
collaborators involved in the previous versions of the heart failure guidelines and members …

Background: Patients with heart failure (HF) have a poor prognosis and are categorized by
ejection fraction (EF). Objectives: This study sought to characterize differences in outcomes …

Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is
increasing in prevalence. HF health expenditures are considerable and will increase …

Heart failure (HF) is an epidemic in healthcare worldwide, including Asia. It appears that HF
will become more serious in the near future, with the epidemiological transition and ageing …

Oxidative stress, defined as an excess production of reactive oxygen species (ROS) relative
to antioxidant defense, has been shown to play an important role in the pathophysiology of …

Heart failure with preserved ejection fraction (HFPEF) is increasingly recognized as a major
public health problem worldwide. Significant advances have been made in our …

Reactive oxygen species (ROS) are important molecules in the living organisms as a part of
many signaling pathways. However, if overproduced, they also play a significant role in the …